Biomea Fusion Files 8-K Report

Ticker: BMEA · Form: 8-K · Filed: Jan 15, 2025 · CIK: 1840439

Biomea Fusion, Inc. 8-K Filing Summary
FieldDetail
CompanyBiomea Fusion, Inc. (BMEA)
Form Type8-K
Filed DateJan 15, 2025
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-K

Related Tickers: BMEA

TL;DR

Biomea Fusion filed a routine 8-K with the SEC on Jan 15, 2025, covering 'Other Events' and financial exhibits.

AI Summary

On January 13, 2025, Biomea Fusion, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial figures detailed in the provided text. The report was filed with the SEC on January 15, 2025.

Why It Matters

This filing indicates Biomea Fusion, Inc. is submitting required regulatory documentation to the SEC, which is standard practice for public companies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report with no disclosed material events, financial changes, or executive actions that would immediately impact the company's risk profile.

Key Players & Entities

  • Biomea Fusion, Inc. (company) — Registrant
  • January 13, 2025 (date) — Earliest event reported
  • January 15, 2025 (date) — Filing date
  • 900 Middlefield Road, 4th Floor Redwood City, CA 94063 (address) — Principal Executive Offices

FAQ

What specific "Other Events" are being reported by Biomea Fusion, Inc. in this 8-K filing?

The provided text for the 8-K filing lists "Other Events" as an item, but does not detail the specific events themselves.

What is the significance of the "Financial Statements and Exhibits" mentioned in the filing?

The filing indicates that "Financial Statements and Exhibits" are part of the report, but the specific content of these statements or exhibits is not detailed in the provided excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on January 13, 2025.

What is Biomea Fusion, Inc.'s principal executive office address?

Biomea Fusion, Inc.'s principal executive offices are located at 900 Middlefield Road, 4th Floor, Redwood City, CA 94063.

What is the SEC file number for Biomea Fusion, Inc.?

The SEC file number for Biomea Fusion, Inc. is 001-40335.

Filing Stats: 947 words · 4 min read · ~3 pages · Grade level 13.6 · Accepted 2025-01-15 16:57:17

Key Financial Figures

  • $0.0001 — nge on which registered Common Stock, $0.0001 par value BMEA The Nasdaq Global Se

Filing Documents

Forward-Looking Statements

Forward-Looking Statements Any forward-looking statements made or incorporated by reference in this Current Report on Form 8-K are based on the Co

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release titled, "Biomea Fusion to Become a Diabetes & Obesity Medicines Company." 99.2 Corporate Slide Presentation of Biomea Fusion, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BIOMEA FUSION, INC. Date: January 15, 2025 By: /s/ Thomas Butler Thomas Butler Principal Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.